| Thomas Charles O'malley, MD | |
|
1 Lemoyne Sq, Suite 201, Lemoyne, PA 17043-1230 | |
| (717) 737-4511 | |
| (717) 909-6659 |
| Full Name | Thomas Charles O'malley |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 1 Lemoyne Sq, Lemoyne, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073593471 | NPI | - | NPPES |
| 527504 | Other | PA | AETNA HMO PROVIDER NUMBER |
| 4633178 | Other | PA | AETNA PPO PROVIDER NUMBER |
| 50026629 | Other | PA | CAPITAL BLUE CROSS |
| 767997 | Other | PA | HIGHMARK BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD048996L (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| All Womens Healthcare Inc | 0547258477 | 8 |
News Archive
Vertex Pharmaceuticals Incorporated today announced final results from the ENVISION study, the second of two pivotal Phase 3 studies of KALYDECO, a medicine in development that targets the defective protein that causes cystic fibrosis.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
Addictions to medicines and drugs are thought to develop over a relatively long period of time. The process involves both structural and functional changes in brain nerve cells that are still poorly understood.
Turf burns and cosmetic body shaving were responsible for the spread of a bacterial skin infection among players on a college football team, according to an article in the November 15 issue of Clinical Infectious Diseases, now available online.
› Verified 7 days ago
| Entity Name | All Womens Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821070061 PECOS PAC ID: 0547258477 Enrollment ID: O20040430001289 |
News Archive
Vertex Pharmaceuticals Incorporated today announced final results from the ENVISION study, the second of two pivotal Phase 3 studies of KALYDECO, a medicine in development that targets the defective protein that causes cystic fibrosis.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
Addictions to medicines and drugs are thought to develop over a relatively long period of time. The process involves both structural and functional changes in brain nerve cells that are still poorly understood.
Turf burns and cosmetic body shaving were responsible for the spread of a bacterial skin infection among players on a college football team, according to an article in the November 15 issue of Clinical Infectious Diseases, now available online.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Charles O'malley, MD 1 Lemoyne Sq, Suite 201, Lemoyne, PA 17043-1230 Ph: (717) 737-4511 | Thomas Charles O'malley, MD 1 Lemoyne Sq, Suite 201, Lemoyne, PA 17043-1230 Ph: (717) 737-4511 |
News Archive
Vertex Pharmaceuticals Incorporated today announced final results from the ENVISION study, the second of two pivotal Phase 3 studies of KALYDECO, a medicine in development that targets the defective protein that causes cystic fibrosis.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
Addictions to medicines and drugs are thought to develop over a relatively long period of time. The process involves both structural and functional changes in brain nerve cells that are still poorly understood.
Turf burns and cosmetic body shaving were responsible for the spread of a bacterial skin infection among players on a college football team, according to an article in the November 15 issue of Clinical Infectious Diseases, now available online.
› Verified 7 days ago
Amanda Powell, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Lemoyne Sq, Suite 201, Lemoyne, PA 17043 Phone: 717-737-4511 Fax: 717-909-6659 | |
Dr. Eric P Fiedler, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1200 Market Street, Unit 17 Pmb 286, Lemoyne, PA 17043 Phone: 717-545-9300 Fax: 717-540-3700 | |
Donald Leslie Adams, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Lemoyne Sq, Suite 201, Lemoyne, PA 17043 Phone: 717-737-4511 Fax: 717-909-6659 | |
Russell Robert Janson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Lemoyne Sq, Suite 201, Lemoyne, PA 17043 Phone: 717-737-4511 Fax: 717-909-6659 | |
Dr. Thomas Ernest Wallin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Lemoyne Sq, Suite 201, Lemoyne, PA 17043 Phone: 717-737-4511 Fax: 717-909-6659 | |
Rose Nancy Eskin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Lemoyne Sq, Suite 201, Lemoyne, PA 17043 Phone: 717-737-4511 Fax: 717-909-6659 |